Loading

Press Release

Sensus Healthcare Announces Low 3% Keloid Recurrence in Multicenter Case Series of 297 Patients Treated with Superficial Radiation Therapy

Sensus Healthcare Announces Low 3% Keloid Recurrence in Multicenter Case Series of 297 Patients Treated with Superficial Radiation Therapy

SRT-100, a Low-energy X-ray Technology, Used at Site of Keloidectomy Treatment BOCA RATON, Fla., Dec. 6, 2018 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a…

See More
Sensus Healthcare Installs First Groundbreaking SRT-100+ Superficial Radiation Therapy System for Treating Keloid Scars

Sensus Healthcare Installs First Groundbreaking SRT-100+ Superficial Radiation Therapy System for Treating Keloid Scars

Dr. Kenrick Spence of Hillcrest Plastic Surgery in Orlando First to Offer System BOCA RATON, Fla., Nov. 29, 2018,/PRNewswire/ — Sensus…

See More
Sensus Healthcare Receives FDA 501(k) Clearance to Market Next-Generation SRT-100+ Superficial Radiation Therapy for Treating Non-Melanoma Skin Cancer and Keloids

Sensus Healthcare Receives FDA 501(k) Clearance to Market Next-Generation SRT-100+ Superficial Radiation Therapy for Treating Non-Melanoma Skin Cancer and Keloids

SRT-100+ Offers Advanced Features for Patients and Doctors, Including Remote Diagnostics and Patient Medical Records Integration, as well as Core…

See More
Sensus Healthcare Brings Groundbreaking SRT-100 Vision System to Israel’s Largest Hospital for Skin Cancer and Keloid Treatment

Sensus Healthcare Brings Groundbreaking SRT-100 Vision System to Israel’s Largest Hospital for Skin Cancer and Keloid Treatment

BOCA RATON, Fla., Oct. 17, 2018 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin…

See More
South Florida Business Journal Recognizes Sensus Healthcare’s Chief Technology Officer at 2018 Technology Awards

South Florida Business Journal Recognizes Sensus Healthcare’s Chief Technology Officer at 2018 Technology Awards

BOCA RATON, Fla., Oct. 16, 2018,/PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin…

See More
Sensus Healthcare Presents at National Cancer Care Alliance Leadership Board and Practice Quarterly Meeting

Sensus Healthcare Presents at National Cancer Care Alliance Leadership Board and Practice Quarterly Meeting

BOCA RATON, Fla., Sept. 7, 2018,/PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ : SRTS ), a medical device company specializing in the non-invasive treatment of…

See More
Sensus Healthcare Announces Strategic Agreement with SkinCure Oncology

Sensus Healthcare Announces Strategic Agreement with SkinCure Oncology

BOCA RATON, Fla., July 12, 2018,/PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin…

See More
Sensus Healthcare to Join Russell Microcap® Index

Sensus Healthcare to Join Russell Microcap® Index

BOCA RATON, Fla., June 25, 2018,/PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma…

See More
Sensus Healthcare to Participate in Panel Discussion at the Cantor Fitzgerald Dermatology & Aesthetics Summit

Sensus Healthcare to Participate in Panel Discussion at the Cantor Fitzgerald Dermatology & Aesthetics Summit

BOCA RATON, Fla., June 12, 2018,/PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma…

See More
Sensus Healthcare to Present at the 8th Annual LD Micro Invitational

Sensus Healthcare to Present at the 8th Annual LD Micro Invitational

LOS ANGELES, CA / ACCESSWIRE / May 29, 2018, / Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing…

See More
Sensus Healthcare Appoints Dr. Isabelle Raymond as Vice President, Clinical Development

Sensus Healthcare Appoints Dr. Isabelle Raymond as Vice President, Clinical Development

BOCA RATON, Fla. (May 8, 2018) – Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive…

See More
Sensus Healthcare Appoints Rita Gable as Vice President of Sales – Oncology

Sensus Healthcare Appoints Rita Gable as Vice President of Sales – Oncology

BOCA RATON, Fla., May 1, 2018,/PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of…

See More
Sensus Healthcare Expands International Business to Meet Rising Patient Demand for Non-Invasive Skin Cancer and Keloid Treatments

Sensus Healthcare Expands International Business to Meet Rising Patient Demand for Non-Invasive Skin Cancer and Keloid Treatments

BOCA RATON, Fla., April 19, 2018 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of…

See More
Sensus Healthcare to Present at the B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium

Sensus Healthcare to Present at the B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium

BOCA RATON, Fla. (March 8, 2018) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive…

See More
Sensus Healthcare Opens Tel Aviv Office to Expand Footprint in Israel, the Middle East & Europe

Sensus Healthcare Opens Tel Aviv Office to Expand Footprint in Israel, the Middle East & Europe

BOCA RATON, Fla., Feb. 7, 2018 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), announced today that the Company is opening a new…

See More
Sensus Healthcare Launches Collaboration with BirchBioMed

Sensus Healthcare Launches Collaboration with BirchBioMed

Sensus Healthcare Launches Collaboration with BirchBioMed to Treat and Prevent Scarring for Keloids Patients Around the World On February 5th,…

See More
Sensus Healthcare Announces Clearance to Market the SRT-100™ in Mexico

Sensus Healthcare Announces Clearance to Market the SRT-100™ in Mexico

BOCA RATON, Fla. (October 31, 2017) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive…

See More
Stratpharma AG & Sensus Healthcare Announce Strategic Collaboration for Transformative Superficial Radiation Therapy & Post-Treatment Care

Stratpharma AG & Sensus Healthcare Announce Strategic Collaboration for Transformative Superficial Radiation Therapy & Post-Treatment Care

Collaboration Brings Sensus Healthcare’s SRT Technology and Stratpharma’s Wound Care Medical Devices Together to Advance Radiation Patient Outcomes San Diego,…

See More
Sensus Healthcare Details Abstract on Keloid Treatment with SRT at the 2017 American Society for Dermatologic Surgery Annual Meeting

Sensus Healthcare Details Abstract on Keloid Treatment with SRT at the 2017 American Society for Dermatologic Surgery Annual Meeting

BOCA RATON, Fla. (October 9, 2017) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the treatment…

See More
American Society for Dermatologic Surgery Annual Meeting to Include Presentation on the Effectiveness of SRT

American Society for Dermatologic Surgery Annual Meeting to Include Presentation on the Effectiveness of SRT

BOCA RATON, Fla., October 2, 2017 – Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment…

See More
Sensus Healthcare Installs Second Next-Generation SRT-100 Vision System in Israel to Treat Skin Cancer and Keloids

Sensus Healthcare Installs Second Next-Generation SRT-100 Vision System in Israel to Treat Skin Cancer and Keloids

New SRT-100 Vision Now at Beilinson Hospital / Rabin Media Center in Petah Tikva BOCA RATON, Fla. – September 20,…

See More

Contact Us

Fill out the form below to find out more!